August 7, 2018

DSM pursues patent infringement lawsuit against Anhui Tiger

Royal DSM, together with its two related operating group companies, DSM Vitamins (Shanghai) Ltd. and DSM Vitamins Trading (Shanghai) Ltd., is in the midst of pursuing a patent infringement lawsuit againsta competitor, Anhui Tiger Biotech Co., Ltd.

The lawsuit, which was served on August 2, is a result ofmisappropriation of intellectual property pertaining to the production of a key ingredient of Biotin (also known as Vitamin B7 and Vitamin H).

According to their complaint, DSM seeks an injunction preventing Tiger from using an innovative patented process for the 'environmentally friendly' manufacture of a key ingredient in Biotin. Additionally, DSM seeks monetary damages that resulted from Tiger's infringement.

Dr. Thomas Beck, Senior Vice President Innovation, DSM Nutritional Products Ltd explained, "Our business has always been focused on bringing new and innovative processes, advanced products and nutritional solutions to our customers in the animal and human micronutrient market."

"Developing and protecting intellectual property is a key component of our strategy to support our significant investments in that market. We are confident in the value and strength of our patent portfolio, and we will defend our intellectual property across the world when necessary. The present litigation underlines DSM's seriousness and confidence in enforcing its IP-rights," he added.